Menu Search
Equities

Q linea AB

QLINEA:STO

Q linea AB

Actions
Health CareMedical Equipment and Services
  • Price (SEK)1.12
  • Today's Change0.016 / 1.45%
  • Shares traded87.26k
  • 1 Year change-63.05%
  • Beta1.1137
Data delayed at least 15 minutes, as of Nov 22 2024 12:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in SEK

The one analyst offering a 12 month price target expects Q linea AB share price to rise to 3.00 in the next year from the last price of 1.10.
High172.7%3.00
Med172.7%3.00
Low172.7%3.00

Earnings history & estimates in SEK

On Nov 05, 2024, Q linea AB reported 3rd quarter 2024 losses of -0.36 per share. This result exceeded the -0.40 consensus loss of the one analyst covering the company and exceeded last year's 3rd quarter results by 35.71%.
The next earnings announcement is expected on Feb 13, 2025.
Average growth rate+3.52%
Q linea AB reported annual 2023 losses of -3.48 per share on Feb 27, 2024.
Average growth rate+10.86%
More ▼

Revenue history & estimates in SEK

Q-linea AB (publ) had 3rd quarter 2024 revenues of 569.00k. This missed the 4.00m estimate of the one analyst following the company. This was 2,486.36% above the prior year's 3rd quarter results.
Average growth rate+597.59%
Q-linea AB (publ) had revenues for the full year 2023 of 4.44m. This was 65.28% below the prior year's results.
Average growth rate+173.40%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.